CCA
NVAX icon

Column Capital Advisors’s Novavax NVAX Stock Holding History

Column Capital Advisors’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1
Closed -$7 – 816
2023
Q2 		$7 Sell
1
-100
-99% -$786 ﹤0.01% 813
2023
Q1 		$700 Buy
101
+31
+44% +$285 ﹤0.01% 786
2022
Q4 		$720 Buy
70
+1
+1% +$18 ﹤0.01% 778
2022
Q3 		$1K Hold
69
– – ﹤0.01% 691
2022
Q2 		$4K Buy
+69
New +$3.57K ﹤0.01% 583
2020
Q2 		– Sell
-1,020
Closed -$14K – 889
2020
Q1 		$14K Hold
1,020
– – 0.01% 356
2019
Q4 		$4K Buy
+1,020
New +$4.42K ﹤0.01% 548

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Column Capital Advisors's NVAX Position: Q3 2023 in Review

Column Capital Advisors sold out of Novavax (NVAX) in Q3 2023, closing a stake of 1 share — an estimated $7 sold.

Column Capital Advisors first reported a position in NVAX in Q4 2019 and held it in 7 quarters. The position peaked at $14K in Q1 2020. 225 funds tracked by Wall St. Rank hold NVAX as of Q3 2023.

  • Column Capital Advisors reported no remaining Novavax position as of Q3 2023 after selling out during the quarter.
  • Column Capital Advisors sold 1 Novavax share in Q3 2023, an estimated $7.
  • Column Capital Advisors first reported a position in Novavax in Q4 2019 and held it in 7 quarters.
  • Column Capital Advisors's Novavax position peaked at $14K in Q1 2020.
  • 225 funds tracked by Wall St. Rank held Novavax as of Q3 2023.

Based on Column Capital Advisors's 13F filing for Q3 2023, filed 3 Nov 2023.